Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.53M Sell
33,662
-740
-2% -$32.7K 0.04% 470
2017
Q1
$1.46M Sell
34,402
-1,720
-5% -$70.1K 0.04% 485
2016
Q4
$1.45M Sell
36,122
-10,900
-23% -$421K 0.04% 484
2016
Q3
$1.83M Buy
47,022
+2,930
+7% +$111K 0.05% 413
2016
Q2
$1.53M Buy
44,092
+17,516
+66% +$607K 0.05% 452
2016
Q1
$917K Buy
26,576
+1,100
+4% +$38.4K 0.03% 615
2015
Q4
$986K Buy
25,476
+2,660
+12% +$103K 0.03% 605
2015
Q3
$893K Buy
22,816
+2,560
+13% +$102K 0.03% 593
2015
Q2
$771K Buy
20,256
+20
+0.1% +$700 0.02% 697
2015
Q1
$668K Buy
20,236
+1,310
+7% +$40.2K 0.02% 899
2014
Q4
$506K Sell
18,926
-1,260
-6% -$32.5K 0.01% 1047
2014
Q3
$491K Buy
20,186
+660
+3% +$16.7K 0.02% 1033
2014
Q2
$495K Sell
19,526
-5,058
-21% -$118K 0.02% 1076
2014
Q1
$529K Sell
24,584
-4,140
-14% -$89.3K 0.02% 1018
2013
Q4
$642K Sell
28,724
-18,678
-39% -$412K 0.02% 923
2013
Q3
$979K Buy
47,402
+1,416
+3% +$30.1K 0.02% 784
2013
Q2
$888K Buy
+45,986
New +$961K 0.02% 776

Other funds holding HOLX

Capstone Asset Management's HOLX Position: Q2 2017 in Review

Capstone Asset Management reduced its Hologic (HOLX) stake by 2.2% in Q2 2017, selling an estimated $32.7K and leaving 33,662 shares worth $1.53M. The position accounts for 0.04% of the portfolio, ranked #470.

Capstone Asset Management first reported a position in HOLX in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.83M in Q3 2016. 505 funds tracked by Wall St. Rank hold HOLX as of Q2 2017.

  • Capstone Asset Management held 33,662 shares of Hologic worth $1.53M as of Q2 2017.
  • Capstone Asset Management sold 740 Hologic shares in Q2 2017, an estimated $32.7K.
  • Hologic made up 0.04% of Capstone Asset Management's portfolio in Q2 2017, its #470 holding.
  • Capstone Asset Management first reported a position in Hologic in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Hologic position peaked at $1.83M in Q3 2016.
  • 505 funds tracked by Wall St. Rank held Hologic as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.